Product Overview
[Drug Name]
Generic Name: Rebamipide Tablets
Trade Name: Mogusida
English Name: Rebamipide Tablets
Chinese Pinyin: Ruibapaite Pian
[Ingredients]
The main ingredient of this product is rebamipide.
[Properties]
This product is a film-coated tablet that appears white after removal of the coating.
[Indications]
For gastric ulcers, acute gastritis, and acute exacerbations of chronic gastritis, improving gastric mucosal lesions (erosion, bleeding, congestion, and edema).
[Dosage and Administration]
Gastric ulcers: Generally, adults take 0.1g (one tablet) orally three times a day, in the morning, evening, and before bed.
For acute gastritis and acute exacerbations of chronic gastritis, improving gastric mucosal lesions (erosion, bleeding, congestion, and edema): Generally, adults take 0.1g (one tablet) orally three times a day.
[Adverse Reactions]
Abdominal distension, constipation, etc. Rebamipide has been reported to cause thirst, dizziness, nausea, vomiting, heartburn, fever, abdominal pain, diarrhea, a foreign body sensation in the throat, abnormal liver function, elevated BuN, breast tenderness, galactorrhea, irregular menstruation, and allergic symptoms (itching, rash, eczema).
[Contraindications]
This product should not be used by those allergic to it.
[Precautions]
1. Carefully weigh the risks and benefits when using this product during pregnancy. Breastfeeding women should discontinue breastfeeding while taking this product.
2. Use with caution in elderly patients. The safety of this product in children has not been established.
3. If allergic reactions such as itching, rash, or eczema occur during treatment, the drug should be discontinued immediately.
[Use in Special Populations]
Precautions for Pediatrics:
The safety of this product in children has not been established (experience is limited).
Precautions for Pregnancy and Lactation:
1. Because the safety of this product during pregnancy has not been established, it should only be used in pregnant women or women who may be pregnant when the therapeutic benefits outweigh the risks. 2. According to animal studies (rat studies), the drug can be transferred into breast milk. Therefore, lactating women should avoid breastfeeding when taking this drug.
Precautions for Elderly Patients:
Since elderly patients generally have reduced physiological functions, they should be aware of digestive side effects.
[Drug Interactions]
No reports have been reported to date.
[Pharmacological Actions]
This product is a gastric mucosal protective agent. It prevents ulcer formation and promotes ulcer healing by increasing gastric mucosal blood flow, prostaglandin E2 synthesis, and gastric mucus secretion. It can scavenge oxygen free radicals, promote the healing of peptic ulcers, and alleviate inflammation.
[Storage]
Store in a dark, airtight container.
[Specifications]
100mg x 12 tablets
[Packaging Size]
Box
[Expiration Period]
36 months
[Approval Number]
National Medicine Standard H20020541
[Manufacturer]
Company Name: Zhejiang Otsuka Pharmaceutical Co., Ltd.
